Cite Filings / MRNA / 0001682852-23-000002
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Moderna, Inc. · Filed 2023-01-03 · Acc 0001682852-23-000002

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , mrna-20230103.htm

Around this filing

  • 2023-01-09 8-K Results of operations · Regulation FD disclosure
  • 2023-01-06 4 Chief Executive Officer sold 80,000 shares at an average $175.84 ($14,067,534)
  • 2023-01-06 4 Director sold 10,000 shares at $182.15 ($1,821,500)
  • 2023-01-03 8-K Regulation FD disclosure
  • 2022-12-30 4 Chief Executive Officer sold 90,000 shares at an average $178.40 ($16,055,833)
  • 2022-12-30 4 Andres Juan sold 2,000 shares at $180.00 ($360,000)
  • 2022-12-13 8-K Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading mrna-20230103.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…